Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPRENORPHINE vs BUROSUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPRENORPHINE vs BUROSUMAB: Safety Overview

Metric BUPRENORPHINE BUROSUMAB
Total FAERS Reports 82,047 674
Deaths Reported 25,813 6
Death Rate 31.5% 0.9%
Hospitalizations 9,467 111
Average Patient Age 47.5 yrs 37.3 yrs
% Female Patients 52.6% 50.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Dr.Reddys Laboratories Inc Kyowa Kirin, Inc.
Route BUCCAL SUBCUTANEOUS
Marketing Status Discontinued N/A